Almonertinib Uses, Dosage, Side Effects and more
Almonertinib is a third-generation EGFR tyrosine kinase inhibitor targeting EGFR-sensitizing and T790M resistance mutations. It is being investigated against advanced or metastatic EGFR-mutated non-small cell lung cancer (NSCLC).
| Attribute | Details |
|---|---|
| Trade Name | Almonertinib |
| Generic | Almonertinib |
| Almonertinib Other Names | Almonertinib, HS-10296 |
| Type | |
| Formula | C30H35N7O2 |
| Weight | Average: 525.657 Monoisotopic: 525.285223395 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
How Almonertinib works
Almonertinib inhibits EGFR tyrosine kinase targeting EGFR-sensitizing and T790M resistance mutations.
